Ticker
GBIOCompany Name
GENERATION BIO COSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -67.79M | -319.33% | $ 21.23M |
3/31/2025 | $ -67.17M | -273.55% | $ 24.56M |
12/31/2024 | $ -126.74M | -637.13% | $ 19.89M |
9/30/2024 | $ -140.39M | -755.53% | $ 18.58M |
6/30/2024 | $ -153.23M | -1163.14% | $ 13.17M |
3/31/2024 | $ -163.81M | -1644.22% | $ 9.96M |
12/31/2023 | $ -121.35M | -2055.37% | $ 5.9M |
9/30/2023 | $ -118.55M | -3917.61% | $ 3.03M |
6/30/2023 | $ -121.52M | -13808.64% | $ 880K |
3/31/2023 | $ -128.47M | 0% | $ 0 |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA / Revenues
(=) EBITDA %
EBITDA % for GENERATION BIO CO is calculated as follows: EBITDA [ $ -77.09M ] / Revenues [ $ 0 ]
(=) EBITDA % [ 0% ]
Minimum
Jun 30, 2023
Maximum
Mar 31, 2025
Average
Median
filtered constituents | 3.29K |
---|---|
min | -74.33% |
max | 97.24% |
average | 16.2% |
median | 14.74% |
std | 26.73% |